2019, Number 2
<< Back
Rev Mex Neuroci 2019; 20 (2)
Clinical guide: discontinuing chronic antiepileptic drug treatment
Loy-Gerala MC, Ibarra-Bravo OM, Márquez-Estudillo MR, Mena-Barranco F, Rogel-Ortiz FJ, Silva-Sánchez SE, Villegas-Peña H, Molina-García A
Language: English
References: 39
Page: 123-128
PDF size: 124.61 Kb.
ABSTRACT
The decision to continue or withdraw the antiepileptic drugs (AEDs) should be taken jointly by the patient, family and/or
caregivers, and the specialist physician, after extensive information and discussion about the risks and benefits of withdrawing
the AED. The patient and family members must understand that there is a risk of the recurrence of seizures with and without
AED. The type of epilepsy, the prognosis, and the patient’s lifestyle should be taken into account. Withdrawal should be carried
out under the supervision of a specialist (clinical neurologist) and will be considered when the patient has been seizure free
for at least 2 years. The treatment must be withdrawn gradually for a period of at least 2-3 months and the antiepileptics
must be removed one by one. Withdrawal of benzodiazepines and barbiturates should be slower, in 6 months or more. An
agreement must be made that in the event of a seizure relapse, the patient must return to taking the last dose before the
dose in which the relapse was presented and request assessment by clinical neurologist.
REFERENCES
Practice parameter: a guideline for discontinuing antiepileptic drugs in seizure- free patients summary statement. Report of the quality standards subcommittee of the American academy of neurology. Neurology. 1996;47:600-2.
Epilepsies: the Diagnosis and Management of the Epilepsies in Adults and Children in Primary and Secondary Care. Withdrawal of Pharmacological Treatment. NICE Clinical Guideline 137. Clinical Guideline [CG137] Fecha de Publicación: Enero 2012 Fecha de Última Actualización; 2018. Available from: https://www.nice.org.uk/guidance/cg137.
Guías Diagnósticas y Terapéuticas de la Sociedad Española de Neurología 2012. Guía Oficial de Práctica Clínica en Epilepsia. Sociedad Española de Neurología; 2012.
Olmez A, Arslan U, Turanli G, Aysun S. Risk of recurrence after drug withdrawal in childhood epilepsy. Seizure. 2009;18:251-6.
Shinnar S, Berg AT, Moshé SL, et al. Discontinuing antiepileptic drugs in children with epilepsy: a prospective study. Ann Neurol. 1994;35:534-45.
Berg AT, Shinnar S. Relapse following discontinuation of antiepileptic drugs: a meta-analysis. Neurology. 1994;44:601-8.
Camfield P, Camfield C. When is it safe to discontinue AED treatment? Epilepsia. 2008;49 Suppl 9:25-8.
Beghi E, Giussani G, Grosso S, et al. Withdrawal of antiepileptic drugs: guidelines of the Italian league against epilepsy. Epilepsia. 2013;54 Suppl 7:2-12.
Lamberink HJ, Otte WM, Geerts AT, et al. Individualised prediction model of seizure recurrence and long-term outcomes after withdrawal of antiepileptic drugs in seizure-free patients: a systematic review and individual participant data meta-analysis. Lancet Neurol. 2017;16:523-31.
Sirven JI, Sperling M, Wingerchuk DM. Early versus late antiepileptic drug withdrawal for people with epilepsy in remission. Cochrane Database Syst Rev. 2001;3:CD001902.
Capovilla MD, Vigevano MD. Topical review: benign idiopathic partial epilepsies in infancy. Child Neurol. 2001;16:874-81.
Peters AC, Brouwer OF, Geerts AT, et al. Randomized prospective study of early discontinuation of antiepileptic drugs in children with epilepsy. Neurology. 1998;50:724-30.
Camfield CS, Camfield PR. Juvenile myoclonic epilepsy 25 years after seizure onset: a population-based study. Neurology. 2009;73:1041-5.
Geithner J, Schneider F, Wang Z, et al. Predictors for long-term seizure outcome in juvenile myoclonic epilepsy: 25-63 years of follow-up. Epilepsia. 2012;53:1379-86.
Specchio LM, Tramacere L, La Neve A, Beghi E. Discontinuing antiepileptic drugs in patients who are seizure free on monotherapy. J Neurol Neurosurg Psychiatry. 2002;72:22-5.
Hixson JD. Stopping antiepileptic drugs: when and why? Curr Treat Options Neurol. 2010;12:434-42.
Tang X, Yu P, Ding D, et al. Risk factors for seizure reoccurrence after withdrawal from antiepileptic drugs in individuals who have been seizure- free for over 2 years. PLoS One. 2017;12:e0181710.
Giussani G, Bianchi E, Canelli V, et al. Antiepileptic drug discontinuation by people with epilepsy in the general population. Epilepsia. 2017;58: 1524‑32.
Incecik F, Herguner OM, Altunbasak S, Mert G, Kiris N. Risk of recurrence after discontinuation of antiepileptic drug therapy in children with epilepsy. J Pediatr Neurosci. 2014;9:100-4.
Schachter SC. Determining when to stop antiepileptic drug treatment. Curr Opin Neurol. 2018;31:211-5.
Lossius MI, Hessen E, Mowinckel P, et al. Consequences of antiepileptic drug withdrawal: a randomized, double-blind study (Akershus study). Epilepsia. 2008;49:455-63.
Lamberink HJ, Otte WM, Geleijns K, Braun KP. Antiepileptic drug withdrawal in medically and surgically treated patients: a meta-analysis of seizure recurrence and systematic review of its predictors. Epileptic Disord. 2015;17:211-28.
Tang L, Xiao Z. Can electroencephalograms provide guidance for the withdrawal of antiepileptic drugs: a meta-analysis. Clin Neurophysiol. 2017; 128:297-302.
Rathore C, Panda S, Sarma PS, Radhakrishnan K. How safe is it to withdraw antiepileptic drugs following successful surgery for mesial temporal lobe epilepsy? Epilepsia. 2011;52:627-35.
Berg AT, Langfitt JT, Spencer SS, Vickrey BG. Stopping antiepileptic drugs after epilepsy surgery: a survey of U.S. Epilepsy center neurologists. Epilepsy Behav. 2007;10:219-22.
McIntosh AM, Kalnins RM, Mitchell LA, et al.Temporal lobectomy: longterm seizure outcome, late recurrence and risks for seizure recurrence. Brain. 2004;127:2018-30.
Kerling F, Pauli E, Lorber B, et al. Drug withdrawal after successful epilepsy surgery: how safe is it? Epilepsy Behav. 2009;15:476-80.
Menon R, Rathore C, Sarma SP, Radhakrishnan K. Feasibility of antiepileptic drug withdrawal following extratemporal resective epilepsy surgery. Neurology. 2012;79:770-6.
Boshuisen K, Uiterwaal C. The timetostop study I. Antiepileptic drug withdrawal policies after childhood epilepsia surgery in Europe. Epilepsia. 2010;51:181-9.
Prognostic index for recurrence of seizures after remission of epilepsy. Medical research council antiepileptic drug withdrawal study group. BMJ. 1993;306:1374-8.
Gherpelli JL, Kok F, dal Forno S, et al. Discontinuing medication in epileptic children: a study of risk factors related to recurrence. Epilepsia. 1992;33:681-6.
Dooley J, Gordon K, Camfield P, Camfield C, Smith E. Discontinuation of anticonvulsant therapy in children free of seizures for 1 year: a prospective study. Neurology. 1996;46:969-74.
Pavlović M, Jović N, Pekmezović T. Antiepileptic drugs withdrawal in patients with idiopathic generalized epilepsy. Seizure. 2011;20:520-5.
Martínez-Juárez IE, Alonso ME, Medina MT, et al. Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain. 2006; 129:1269-80.
Tennison M, Greenwood R, Lewis D, Thorn M. Discontinuing antiepileptic drugs in children with epilepsy. A comparison of a six-week and a nine-month taper period. N Engl J Med. 1994;330:1407-10.
Serra JG, Montenegro MA, Guerreiro MM. Antiepileptic drug withdrawal in childhood: does the duration of tapering off matter for seizure recurrence? J Child Neurol. 2005;20:624-6.
Bonnett LJ, Shukralla A, Tudur-Smith C, Williamson PR, Marson AG. Seizure recurrence after antiepileptic drug withdrawal and the implications for driving: further results from the MRC antiepileptic drug withdrawal study and a systematic review. J Neurol Neurosurg Psychiatry. 2011;82: 1328-33.
Overweg J. Withdrawal of antiepileptic drugs (AEDs) in seizure-free patients, risk factors for relapse with special attention for the EEG. Seizure. 1995;4:19-36.
Tinuper P, Avoni P, Riva R, et al. The prognostic value of the electroencephalogram in antiepileptic drug withdrawal in partial epilepsies. Neurology. 1996;47:76-8.
Full text